Search research articles
Contact Us
Filters
Showing results (211-220 of 339) with videos related to
Page
of 34
Sort By:
British Journal of Haematology
|
January 25, 2003
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission
Lyle C Feinstein, Brenda M Sandmaier, Ute Hegenbart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2012
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation
Marcelo C Pasquini, Steven Devine, Adam Mendizabal, et al.
Blood
|
August 23, 2014
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report
Fabiana Ostronoff, Megan Othus, Robert B Gerbing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 20, 2009
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study
Fabrizio Carnevale-Schianca, Wendy Leisenring, Paul J Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 17, 2002
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease
Terry Furlong, Wendy Leisenring, Rainer Storb, et al.
Journal of Oncology Practice
|
September 23, 2010
Benchmarks in clinical productivity: a national comprehensive cancer network survey
F Marc Stewart, Robert L Wasserman, Clara D Bloomfield, et al.
British Journal of Haematology
|
November 30, 2010
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia
Anjali S Advani, Holly M Gundacker, Olga Sala-Torra, et al.
Blood
|
April 13, 2012
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes
Claudio G Brunstein, Mary Eapen, Kwang Woo Ahn, et al.
Blood
|
October 24, 2002
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol
Martin S Tallman, Janet W Andersen, Charles A Schiffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2011
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia
Roland B Walter, Ted A Gooley, Brent L Wood, et al.
Page
of 34
Search research articles
Search
Showing results (211-220 of 339) with videos related to
Sort By:
Page
of 34
British Journal of Haematology
|
January 25, 2003
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission
Lyle C Feinstein, Brenda M Sandmaier, Ute Hegenbart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2012
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation
Marcelo C Pasquini, Steven Devine, Adam Mendizabal, et al.
Blood
|
August 23, 2014
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report
Fabiana Ostronoff, Megan Othus, Robert B Gerbing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 20, 2009
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study
Fabrizio Carnevale-Schianca, Wendy Leisenring, Paul J Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 17, 2002
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease
Terry Furlong, Wendy Leisenring, Rainer Storb, et al.
Journal of Oncology Practice
|
September 23, 2010
Benchmarks in clinical productivity: a national comprehensive cancer network survey
F Marc Stewart, Robert L Wasserman, Clara D Bloomfield, et al.
British Journal of Haematology
|
November 30, 2010
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia
Anjali S Advani, Holly M Gundacker, Olga Sala-Torra, et al.
Blood
|
April 13, 2012
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes
Claudio G Brunstein, Mary Eapen, Kwang Woo Ahn, et al.
Blood
|
October 24, 2002
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol
Martin S Tallman, Janet W Andersen, Charles A Schiffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2011
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia
Roland B Walter, Ted A Gooley, Brent L Wood, et al.
Page
of 34